ESN-JJ

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameESN-JJ
Drug Alias NameG-protein coupled receptor-43 modulator (Euroscreen/Ortho-McNeil-Janssen)ESN-JJ
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 2 modulators
TargetsFree fatty acid receptor 2
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOgeda SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOgeda SAJanssen Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A